-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Treatment of Langerhans Cell Histiocytosis: Role of BRAF/MAPK Inhibition

Program: Education Program
Session: Recent Advances in Histiocytic Neoplasms
Saturday, December 5, 2015, 2:00 PM-3:30 PM
W230, Level 2 (Orange County Convention Center)
Sunday, December 6, 2015, 9:30 AM-11:00 AM
W331, Level 3 (Orange County Convention Center)

Sheila Weitzman, MB BCh, FRCP

Pediatric Hematology-Oncology/ Universiy of Toronto, Hospital For Sick Children, Toronto, ON, Canada

Disclosures: No relevant conflicts of interest to declare.

See more of: Recent Advances in Histiocytic Neoplasms
See more of: Education Program
<< Previous Presentation | Next Presentation >>